In this series of HCPLive® State of the Science, 4 experts discuss knowledge and treatment in the cardiovascular risk management space.
Institutional Perspectives in Cardiology: Cardiovascular Risk Management
Dr. Manesh Patel shares perspective on the "renaissance of anti-thrombotic therapy" for patients at risk of cardiovascular events.
Advertisement
Schuyler Jones, MD discusses risk stratification in CAD/PAD and treatments aimed at atherothrombosis.
Growing evidence shows promise of stroke prevention with anti-thrombotic therapy in patients with AF.
Advertisement
Advertisement
Trending on HCPLive
1
Sebetralstat Shows QoL Gains on Top of HAE Prophylaxis in KONFIDENT-S
2
The HCPFive: Top News for Healthcare Providers from the Week of 07/19
3
FDA Approves Furosemide Injection (Furoscix ReadyFlow) for Edema in HF, CKD
4
Sanofi Announces Discontinuation of Amlitelimab for Atopic Dermatitis
5